Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Metabolomic profiling to develop blood biomarkers for Parkinson's disease.

Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS, Flint Beal M.

Brain. 2008 Feb;131(Pt 2):389-96. doi: 10.1093/brain/awm304.

2.

Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease.

Bolner A, Pilleri M, De Riva V, Nordera GP.

Clin Lab. 2011;57(11-12):859-66.

PMID:
22239015
3.

8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.

Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC.

Am J Kidney Dis. 2000 Nov;36(5):934-44.

PMID:
11054349
4.

Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease.

Chen CM, Liu JL, Wu YR, Chen YC, Cheng HS, Cheng ML, Chiu DT.

Neurobiol Dis. 2009 Mar;33(3):429-35. doi: 10.1016/j.nbd.2008.11.011. Epub 2008 Dec 9.

PMID:
19110057
5.

Metabolomic profiling in LRRK2-related Parkinson's disease.

Johansen KK, Wang L, Aasly JO, White LR, Matson WR, Henchcliffe C, Beal MF, Bogdanov M.

PLoS One. 2009 Oct 22;4(10):e7551. doi: 10.1371/journal.pone.0007551.

6.

Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.

Tarng DC, Wen Chen T, Huang TP, Chen CL, Liu TY, Wei YH.

J Am Soc Nephrol. 2002 May;13(5):1321-30.

8.

3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.

Lewitt PA, Li J, Lu M, Beach TG, Adler CH, Guo L; Arizona Parkinson's Disease Consortium.

Mov Disord. 2013 Oct;28(12):1653-60. doi: 10.1002/mds.25555. Epub 2013 Jul 19.

PMID:
23873789
9.

Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.

Kikuchi A, Takeda A, Onodera H, Kimpara T, Hisanaga K, Sato N, Nunomura A, Castellani RJ, Perry G, Smith MA, Itoyama Y.

Neurobiol Dis. 2002 Mar;9(2):244-8.

PMID:
11895375
10.

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.

Seet RC, Lee CY, Lim EC, Tan JJ, Quek AM, Chong WL, Looi WF, Huang SH, Wang H, Chan YH, Halliwell B.

Free Radic Biol Med. 2010 Feb 15;48(4):560-6. doi: 10.1016/j.freeradbiomed.2009.11.026. Epub 2009 Dec 4.

PMID:
19969070
11.

A new and fast methodology to assess oxidative damage in cardiovascular diseases risk development through eVol-MEPS-UHPLC analysis of four urinary biomarkers.

Mendes B, Silva P, Mendonça I, Pereira J, Câmara JS.

Talanta. 2013 Nov 15;116:164-72. doi: 10.1016/j.talanta.2013.04.064. Epub 2013 May 3.

PMID:
24148388
12.

Uric acid in Parkinson's disease.

Schlesinger I, Schlesinger N.

Mov Disord. 2008 Sep 15;23(12):1653-7. doi: 10.1002/mds.22139. Review.

PMID:
18618666
13.

Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease.

Cornetta T, Palma S, Aprile I, Padua L, Tonali P, Testa A, Cozzi R.

Cell Biol Toxicol. 2009 Aug;25(4):321-30. doi: 10.1007/s10565-008-9086-6. Epub 2008 Jun 4.

PMID:
18523852
14.

Low plasma uric acid level in Parkinson's disease.

Annanmaki T, Muuronen A, Murros K.

Mov Disord. 2007 Jun 15;22(8):1133-7.

PMID:
17443703
16.

Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.

Agil A, Durán R, Barrero F, Morales B, Araúzo M, Alba F, Miranda MT, Prieto I, Ramírez M, Vives F.

J Neurol Sci. 2006 Jan 15;240(1-2):31-6. Epub 2005 Oct 10.

PMID:
16219327
17.

Lower serum UA levels in Parkinson's disease patients in the Chinese population.

Zhang HN, Guo JF, He D, Lei LF, Wang YQ, Wang CY, Tan LM, Yan XX, Shen L, Tang BS.

Neurosci Lett. 2012 Apr 18;514(2):152-5. doi: 10.1016/j.neulet.2012.02.077. Epub 2012 Mar 3.

PMID:
22405811
18.

Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats.

Yasuhara T, Hara K, Sethi KD, Morgan JC, Borlongan CV.

Brain Res. 2007 Feb 16;1133(1):49-52. Epub 2006 Dec 26.

PMID:
17188662
19.

Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients.

Migliore L, Scarpato R, Coppede F, Petrozzi L, Bonuccelli U, Rodilla V.

Int J Hyg Environ Health. 2001 Oct;204(1):61-6.

PMID:
11725348
20.

Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.

Andican G, Konukoglu D, Bozluolcay M, Bayülkem K, Firtiına S, Burcak G.

Acta Neurol Belg. 2012 Jun;112(2):155-9. doi: 10.1007/s13760-012-0015-3. Epub 2012 Feb 9.

PMID:
22426659
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk